Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxygen-enriched air is a gas mixture containing a concentration of oxygen greater than the approximately 21% found in standard atmospheric air. In clinical practice, it is used to provide supplemental oxygen to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or acute respiratory distress to maintain adequate arterial oxygen saturation. In the provided clinical context, a 30% oxygen-enriched air mixture was used as a control to evaluate the efficacy of heliox (a helium-oxygen mixture) in children hospitalized with acute severe asthma. The primary active component is oxygen, which is essential for aerobic metabolism and cellular ATP production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxygen-enriched air.